Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
Kartha VK, Alamoud KA, Sadykov K, Nguyen BC, Laroche F, Feng H, Lee J, Pai SI, Varelas X, Egloff AM, Snyder-Cappione JE, Belkina AC, Bais MV, Monti S, Kukuruzinska MA.
Kartha VK, et al. Among authors: varelas x.
Genome Med. 2018 Jul 20;10(1):54. doi: 10.1186/s13073-018-0569-7.
Genome Med. 2018.
PMID: 30029671
Free PMC article.